These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34975333)

  • 21. Yap methylation-induced FGL1 expression suppresses anti-tumor immunity and promotes tumor progression in KRAS-driven lung adenocarcinoma.
    Jiang J; Ye P; Sun N; Zhu W; Yang M; Yu M; Yu J; Zhang H; Gao Z; Zhang N; Guo S; Ji Y; Li S; Zhang C; Miao S; Chai M; Liu W; An Y; Hong J; Wei W; Zhang S; Qiu H
    Cancer Commun (Lond); 2024 Nov; 44(11):1350-1373. PubMed ID: 39340215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a high-throughput TR-FRET screening assay for LAG-3/FGL1 interaction.
    Abdel-Rahman SA; Zhang L; Gabr MT
    SLAS Discov; 2023 Jun; 28(4):188-192. PubMed ID: 37121273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
    Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognition.
    Ming Q; Celias DP; Wu C; Cole AR; Singh S; Mason C; Dong S; Tran TH; Amarasinghe GK; Ruffell B; Luca VC
    Nat Immunol; 2022 Jul; 23(7):1031-1041. PubMed ID: 35761082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinogen-like 1: A hepatokine linking liver physiology to hematology.
    Personnaz J; Guillou H; Kautz L
    Hemasphere; 2024 Jul; 8(7):e115. PubMed ID: 38966209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy.
    Qian Y; Sun Y; Shi P; Zhou X; Zhang Q; Dong Q; Jin S; Qiu L; Niu X; Zhou X; Zhao W; Wu Y; Zhai W; Gao Y
    Acta Pharm Sin B; 2024 Mar; 14(3):1150-1165. PubMed ID: 38486998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in Fibrinogen-like 1 (
    Piórkowska K; Żukowski K; Ropka-Molik K; Tyra M
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eicosapentaenoic Acid Inhibits
    Chiu CF; Hsu MI; Yeh HY; Park JM; Shen YS; Tung TH; Huang JJ; Wu HT; Huang SY
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics identifies a novel role of fibrinogen-like protein 1 in Crohn's disease.
    Sun XL; Qiao LC; Gong J; Wen K; Xu ZZ; Yang BL
    World J Gastroenterol; 2021 Sep; 27(35):5946-5957. PubMed ID: 34629811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of Fibrinogen-like proteins in Cancer.
    Yu J; Li J; Shen J; Du F; Wu X; Li M; Chen Y; Cho CH; Li X; Xiao Z; Zhao Y
    Int J Biol Sci; 2021; 17(4):1079-1087. PubMed ID: 33867830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two fibrinogen-like proteins, FGL1 and FGL2 are disulfide-linked subunits of oligomers that specifically bind nonviable spermatozoa.
    Nagdas SK; Winfrey VP; Olson GE
    Int J Biochem Cell Biol; 2016 Nov; 80():163-172. PubMed ID: 27732889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immune checkpoint receptor LAG3: Structure, function, and target for cancer immunotherapy.
    Mariuzza RA; Shahid S; Karade SS
    J Biol Chem; 2024 May; 300(5):107241. PubMed ID: 38556085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Fibrinogen-like Protein 1 in Tumor Recurrence Following Hepatectomy.
    Shafieizadeh Z; Shafieizadeh Z; Davoudi M; Afrisham R; Miao X
    J Clin Transl Hepatol; 2024 Apr; 12(4):406-415. PubMed ID: 38638375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer.
    Sun C; Gao W; Liu J; Cheng H; Hao J
    Respir Res; 2020 Aug; 21(1):210. PubMed ID: 32778129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The regulation role and diagnostic value of fibrinogen-like protein 1 revealed by pan-cancer analysis.
    Yi W; Qiao T; Yang Z; Hu L; Sun M; Fan H; Xu Y; Lv Z
    Mater Today Bio; 2022 Dec; 17():100470. PubMed ID: 36345363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of LH3 and GLT25D1 for glucosyl-galactosyl-hydroxylation on non-collagen-like domain of FGL1.
    Mori K; Suzuki T; Miura K; Dohmae N; Simizu S
    Biochem Biophys Res Commun; 2021 Jun; 560():93-98. PubMed ID: 33984770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma.
    Lv Z; Cui B; Huang X; Feng HY; Wang T; Wang HF; Xuan YD; Li HZ; Ma X; Huang Y; Zhang X
    Front Oncol; 2021; 11():756843. PubMed ID: 34956878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unlocking therapeutic potential: Targeting lymphocyte activation Gene-3 (LAG-3) with fibrinogen-like protein 1 (FGL1) in systemic lupus erythematosus.
    Wang B; Zhang B; Wu M; Xu T
    J Transl Autoimmun; 2024 Dec; 9():100249. PubMed ID: 39228513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin and immunotherapy: a Faustian bargain?
    Goethe EA; Heimberger AB; Rao G
    J Clin Invest; 2023 May; 133(9):. PubMed ID: 37115694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen-Like Protein 1 as a Novel Biomarker of Psoriasis Severity.
    Sun X; Liu L; Chen S; Wang J; Cai X; Song J; Zhou M; Guo D; Kuai L; Ding X; Li B; Li X
    J Inflamm Res; 2022; 15():4637-4647. PubMed ID: 35996685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.